Newswire

Tag: sen john barrasso

Senate hearing focuses on securing the entire U.S. nuclear fuel cycle

March 14, 2023, 9:39AMEdited March 14, 2023, 9:38AMNuclear News
In this screenshot from a video recording of the hearing, Huff, Wagner, and Dominguez answer a series of questions from Sen. Manchin

“Right now, our country is deficient in nearly every aspect of the fuel cycle. This must change and it must change quickly,” said Sen. Joe Manchin (D., W.V.), chairman of the Senate Committee on Energy and Natural Resources (ENR), as he opened a Full Committee Hearing to Examine the Nuclear Fuel Cycle on March 9. “Whether it is uranium mining, milling, conversion, enrichment, nuclear fuel fabrication, power generation, or nuclear waste storage and disposal, there is much work to be done, starting with conversion and enrichment. Simply put, Russia dominates the global market, representing nearly half of the international capacity for both processes.”

Barrasso introduces bill to prioritize HALEU supply chain and demo reactor needs

April 8, 2022, 9:20AMNuclear News
Ingots of HALEU derived from pyroprocessing of EBR-II driver fuel at Idaho National Laboratory. (Photo: INL)

On April 7, U.S. Sen. John Barrasso (R., Wyo.), ranking member of the Senate Committee on Energy and Natural Resources, introduced the Fueling Our Nuclear Future Act of 2022. The bill would ensure a domestic supply of high-assay low-enriched uranium (HALEU) for advanced nuclear reactors by directing the Department of Energy to prioritize establishing a domestic HALEU enrichment capability and to use enriched uranium held by the DOE and the National Nuclear Security Administration to fuel advanced reactor demonstrations until U.S. commercial enrichment is available. The bill explicitly excludes uranium sourced or processed by any entity owned or controlled by the governments of Russia and China.

ANS Winter Meeting: What it will take to “Fuel our Nuclear Future"

December 1, 2021, 3:01PMNuclear News

The 2021 ANS Winter Meeting and Technology Expo began this morning with a Opening Plenary Session chaired by Winter Meeting general chair Amir Vexler, president and chief executive officer of Orano USA. It was an opportunity to both celebrate achievements that are already building a “Nuclear Future” and to identify needs and challenges ahead.

Influential speakers from the U.S. Congress, the Department of Energy, and the Nuclear Energy Institute joined ANS president Steven Nesbit and ANS CEO/executive director Craig Piercy to explore key issues associated with the front end of the nuclear fuel cycle, including supply and demand for high-assay, low-enriched uranium (HALEU). They didn’t stop there, however. They took questions from an in-person and virtual audience that probed other requirements of a sustainable nuclear future, including fueling a human resources pipeline.

Senators probe nuclear priorities: HALEU, hydrogen, reactor siting, and more

November 5, 2021, 9:29AMNuclear News
From left, Shannon Bragg-Sitton, Paul Chodak, and Michael J. Guastella appear before the Senate Committee on Energy and Natural Resources on November 4.

As Congress awaited key votes yesterday on spending bills that include production tax credits for at-risk plants and a new amendment adding $500 million in supplemental funding over five years to increase the availability of high-assay low-enriched uranium (HALEU), the U.S. Senate Energy and Natural Resources Committee held a Full Committee Hearing On Potential Non-Electric Applications Of Civilian Nuclear Energy. Sen. Joe Manchin (D., W.V.), chairman of the committee, emphasized that “advanced nuclear reactors hold enormous potential to provide opportunity to communities across the country with zero-emission baseload power” and made it clear he expects new reactors to replace retiring coal plants in his home state of West Virginia.

Speaking before the committee were Shannon Bragg-Sitton of Idaho National Laboratory, Paul Chodak III of American Electric Power, and Michael J. Guastella of the Council of Radionuclides and Radiopharmaceuticals.